Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-31.6	-30.01	-32.11	-49.91	1.94	-72.18
Depreciation & Amortization	0.03	0.03	0.01	0.1	0.18	0.16
Share-Based Compensation	2.03	1.97	4.11	5.22	9.7	9.17
Other Operating Activities	8.78	13.22	3.35	19.98	-45.64	19.42
Operating Cash Flow	-20.76	-14.78	-24.65	-24.6	-33.82	-43.43
Capital Expenditures	0	0	-0.02	0	0	0
Change in Investments	0	0	0	0	24.53	14.08
Investing Cash Flow	0	0	-0.02	0	24.53	14.08
Share Issuance / Repurchase	20	20	0	0	13.24	0.52
Other Financing Activities	-0.4	-0.4	-0	60	-	-
Financing Cash Flow	19.6	19.6	-0	60	13.24	0.52
Net Cash Flow	-1.16	4.82	-24.66	35.4	3.94	-28.82
Free Cash Flow	-20.76	-14.78	-24.66	-24.6	-33.82	-43.43
Free Cash Flow Margin	-	-	-	-	-82.14%	-
Free Cash Flow Per Share	-2.74	-2.27	-4.62	-4.61	-6.63	-8.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).